PTC Therapeutics (P91) Financial Statements

1 Followers

PTC Therapeutics Financial Overview

PTC Therapeutics's market cap is currently CHF4.79B. The company's EPS TTM is CHF-0.49; its P/E ratio is -146.51; PTC Therapeutics is scheduled to report earnings on July 30, 2026, and the estimated EPS forecast is CHF0.22. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 1.73B	$ 806.78M	$ 937.82M	$ 698.80M	$ 538.59M
Gross Profit	$ 1.66B	$ 749.38M	$ 872.34M	$ 654.12M	$ 506.26M
Operating Income	$ 856.51M	$ -302.57M	$ -439.50M	$ -447.41M	$ -374.44M
EBITDA	$ 887.66M	$ -120.46M	$ -330.34M	$ -367.78M	$ -368.18M
Net Income	$ 682.64M	$ -363.30M	$ -626.60M	$ -559.02M	$ -523.90M
Balance Sheet
Cash & Short-Term Investments	$ 1.95B	$ 1.14B	$ 876.74M	$ 410.70M	$ 773.38M
Total Assets	$ 2.90B	$ 1.71B	$ 1.90B	$ 1.71B	$ 1.94B
Total Debt	$ 2.71B	$ 2.47B	$ 2.23B	$ 1.46B	$ 1.27B
Net Debt	$ 1.72B	$ 1.69B	$ 1.64B	$ 1.18B	$ 1.08B
Total Liabilities	$ 3.10B	$ 2.80B	$ 2.71B	$ 2.05B	$ 1.94B
Stockholders' Equity	$ -205.31M	$ -1.10B	$ -818.55M	$ -347.09M	$ 1.44M
Cash Flow
Free Cash Flow	$ 411.18M	$ -181.94M	$ -279.04M	$ -509.11M	$ -336.66M
Operating Cash Flow	$ 711.20M	$ -107.69M	$ -158.42M	$ -356.65M	$ -251.33M
Investing Cash Flow	$ -861.98M	$ 44.18M	$ -176.74M	$ 290.18M	$ 219.18M
Financing Cash Flow	$ 331.09M	$ 255.87M	$ 646.40M	$ 167.95M	$ 20.88M

Currency in USD

PTC Therapeutics Earnings and Revenue History

Income Statement >

PTC Therapeutics Debt to Assets

Balance Sheet >

PTC Therapeutics Cash Flow

Cash Flow >

PTC Therapeutics Forecast EPS vs Actual EPS

Earnings >